Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Researchers at the National University of Singapore (NUS) have hit upon new technologies to deliver a double whammy to ...

The "Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more" ...

Diabetes affects millions worldwide, often triggering complications such as insulin resistance and fatty liver disease. To ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication ...

Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese ...

Endometriosis is a condition where tissue similar to the lining of the womb starts to grow in other places, such as the ...

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...

Month after claiming Ozempic left her 'bedridden', Amy Schumer revealed she's been using a different diabetes medication as a ...

Discover 10 powerful lifestyle modifications that can prevent and potentially reverse type 2 diabetes naturally, from ...

Mounjaro’s been great,” the comedian said in an Instagram video. “I’m having a really good experience with it and I wanted to ...